journal article·2023-05Open access

Efficient Delivery of GSDMD‐N mRNA by Engineered Extracellular Vesicles Induces Pyroptosis for Enhanced Immunotherapy

Yuqi Xing, Feiyu Zhang, Panpan Ji, Mengying Wei, Chunhui Yin, Angang Yang, Guodong Yang, Jing Zhao

Small· Volume 19· Issue 20

Abstract

Abstract Pyroptosis is a newly discovered inflammatory form of programmed cell death, which promotes systemic immune response in cancer immunotherapy. GSDMD is one of the key molecules executing pyroptosis, while therapeutical delivery of GSDMD to tumor cells is of great challenge. In this study, an extracellular vesicles‐based GSDMD‐N mRNA delivery system (namely EVTx) is developed for enhanced cancer immunotherapy, with GSDMD‐N mRNA encapsulated inside, Ce6 (Chlorin e6 (Ce6), a hydrophilic sensitizer) incorporated into extracellular vesicular membrane, and HER2 antibody displayed onto the surface. Briefly, GSDMD‐N mRNA is translationally repressed in donor cells by optimized puromycin, ensuring the cell viability and facilitating the mRNA encapsulation into extracellular vesicles. When targeted and delivered into HER2+ breast cancer cells by the engineered extracellular vesicles, the translational repression is unleashed in the recipient cells as the puromycin is diluted and additionally inactivated by sonodynamic treatment as the extracellular vesicles are armed with Ce6, allowing GSDMD‐N translation and pyroptosis induction. In addition, sonodynamic treatment also induces cell death in the recipient cells. In the SKBR3‐ and HER2 transfected 4T1‐ inoculated breast tumor mouse models, the engineered EVTx efficiently induces a powerful tumor immune response and suppressed tumor growth, providing a nanoplatform for cancer immunotherapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · Inflammasome and immune disorders · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

The State Laboratory of Cancer Biology Department of Biochemistry and Molecular Biology Fourth Military Medical University Xi'an Shaanxi 710032 China

Department of Cardiology Xijing Hospital Fourth Military Medical University Xi'an Shaanxi 710032 China

The State Laboratory of Cancer Biology Department of Gastrointestinal Surgery Xijing Hospital of Digestive Diseases Fourth Military Medical University Xi'an Shaanxi 710032 China

The State Laboratory of Cancer Biology Department of Immunology Fourth Military Medical University No. 169 Changlexi Road Xi'an Shaanxi 710032 China

Funding

National Natural Science Foundation of China

References (49)

Show source-provided references
1. 10.1038/s41418-018-0103-x10.1038/s41418-018-0103-x ↗
2. 10.1038/s41591-018-0091-x10.1038/s41591-018-0091-x ↗
3. 10.1002/advs.20190172810.1002/advs.201901728 ↗
4. 10.1002/advs.20200223210.1002/advs.202002232 ↗
5. 10.1038/s41467-021-23832-310.1038/s41467-021-23832-3 ↗
6. 10.1016/j.tibs.2016.10.00410.1016/j.tibs.2016.10.004 ↗
7. 10.1016/j.tcb.2014.12.00910.1016/j.tcb.2014.12.009 ↗
8. 10.1038/s41467-020-20357-z10.1038/s41467-020-20357-z ↗
9. 10.1182/blood-2017-12-82085210.1182/blood-2017-12-820852 ↗
10. 10.1186/s13046-021-02065-810.1186/s13046-021-02065-8 ↗
11. 10.1038/nature1859010.1038/nature18590 ↗
12. 10.1038/s41586-018-0058-610.1038/s41586-018-0058-6 ↗
13. 10.1038/nature1551410.1038/nature15514 ↗
14. 10.1038/cr.2016.10010.1038/cr.2016.100 ↗
15. 10.1111/j.1600-0854.2011.01225.x10.1111/j.1600-0854.2011.01225.x ↗
16. 10.1126/science.aau697710.1126/science.aau6977 ↗
17. 10.1186/s12943-019-0991-510.1186/s12943-019-0991-5 ↗
18. 10.1016/j.jconrel.2020.12.05310.1016/j.jconrel.2020.12.053 ↗
19. 10.1038/ncomms802910.1038/ncomms8029 ↗
20. 10.1038/mt.2012.16110.1038/mt.2012.161 ↗
21. 10.1016/j.biomaterials.2013.11.08310.1016/j.biomaterials.2013.11.083 ↗
22. 10.1016/j.biomaterials.2018.06.01610.1016/j.biomaterials.2018.06.016 ↗
23. 10.1038/s41586-020-2079-110.1038/s41586-020-2079-1 ↗
24. 10.1038/nature2239310.1038/nature22393 ↗
25. 10.1038/s41556-020-0575-z10.1038/s41556-020-0575-z ↗
26. 10.1126/science.abb981810.1126/science.abb9818 ↗
27. 10.1038/s41422-021-00506-910.1038/s41422-021-00506-9 ↗
28. 10.1038/s41586-020-2071-910.1038/s41586-020-2071-9 ↗
29. 10.1038/nature1554110.1038/nature15541 ↗
30. 10.1038/s41467-018-03733-810.1038/s41467-018-03733-8 ↗
31. 10.1080/20013078.2020.181671010.1080/20013078.2020.1816710 ↗
32. 10.1038/s41422-021-00491-z10.1038/s41422-021-00491-z ↗
33. 10.1038/s41467-022-28280-110.1038/s41467-022-28280-1 ↗
34. 10.1038/nchembio.198110.1038/nchembio.1981 ↗
35. 10.1021/acscentsci.9b0084310.1021/acscentsci.9b00843 ↗
36. 10.1016/j.drudis.2013.10.01110.1016/j.drudis.2013.10.011 ↗
37. 10.1016/j.cell.2020.11.01010.1016/j.cell.2020.11.010 ↗
38. 10.1038/s41467-019-14199-710.1038/s41467-019-14199-7 ↗
39. 10.1038/s41467-021-25197-z10.1038/s41467-021-25197-z ↗
40. 10.1038/s41467-021-22678-z10.1038/s41467-021-22678-z ↗
41. 10.1016/j.immuni.2013.07.01210.1016/j.immuni.2013.07.012 ↗
42. 10.1186/s12943-022-01515-x10.1186/s12943-022-01515-x ↗
43. 10.1016/j.immuni.2013.07.00510.1016/j.immuni.2013.07.005 ↗
44. 10.1038/s41467-018-03473-910.1038/s41467-018-03473-9 ↗
45. 10.1038/nrc323910.1038/nrc3239 ↗
46. 10.1021/acs.jmedchem.1c0001010.1021/acs.jmedchem.1c00010 ↗
47. 10.1038/s41467-020-14642-010.1038/s41467-020-14642-0 ↗
48. 10.1038/s41467-021-24604-910.1038/s41467-021-24604-9 ↗
49. 10.1016/j.biomaterials.2020.12014210.1016/j.biomaterials.2020.120142 ↗